csm_centogene-revolutionising-genetic-solutions_why-choose-header_889fbcb66f

科學研究發表

想了解最新的科學研究進展嗎?

A new genetic cause of neurological disease

BLOC1S1 variants cause lysosomal and autophagic defects resulting in a hypomyelinating leukodystrophy with epileptic encephalopathy

Through genetic, clinical, and functional evidence, we demonstrated that loss-of-function of BLOC1S1 results in an autosomal recessive neurological disorder characterized by prominent leukodystrophy. The findings will be published in collaboration with the Children’s Hospital of Philadelphia and several centers worldwide in the prestigious American Journal of Human Genetics. Four of the seven families studied were identified at CENTOGENE, originating from Portugal, Turkey, and the KSA.

Author(s): Bertoli-Avella, Aida M., MD
Read publication

RNA-Seq as the Next Step in Genetic Diagnostics

Experience the power of multiomic diagnostics: We have implemented RNA-seq using the same dried blood spot sample provided for genomic testing.

Experience the power of multiomic diagnostics: We have implemented RNA-seq using the same dried blood spot sample provided for genomic testing. This streamlined approach enhances our routine diagnostics by clarifying the splicing effect of relevant noncoding variants and delivering more comprehensive genetic testing.

Author(s): Bertoli-Avella, Aida M., MD
Read publication

Elucidating the Mechanisms That Underlies Genetic Parkinson’s Disease

Parkinson’s Disease Publication: African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1.

The mechanisms by which GBA1 mutations cause Parkinson’s Disease (PD) are incompletely understood. Supported by the Michael J Fox Foundation, CENTOGENE generated corresponding insights for an unusual GBA1 mutation that was only recently discovered. The findings were published in collaboration with NIH researchers in Nature Structural & Molecular Biology, a prestigious journal from the Nature Publishing Group.

Author(s): 拉德費爾特,曼迪
Read publication

Two Distinct Disorders Resulting From Mutations in One Gene

Publication: Upregulation vs. loss of function of NTRK2 in 44 affected individuals leads to two distinct neurodevelopmental disorders

Mutations in a given gene are usually associated with a single genetic disorder. Combined analysis of published case reports and data from CENTOGENE’s uniquely large database revealed that the NTRK2 gene is a rare exception by being associated with two distinct disorders. The finding was published in Genetics in Medicine, a leading journal in the field.

Author(s): Zonic,艾米爾
Read publication

Better Understanding of a Novel Form of Monogenic Parkinson’s Disease

Parkinson’s Disease Publication: Genetic and Epidemiological Insights into RAB32-Linked Parkinson’s Disease

The link between the RAB32 gene and Parkinson’s Disease (PD) has been established only recently; it is not yet fully understood. CENTOGENE’s researchers thus analyzed relevant data from the company’s database. The findings, which shed light on important genetic and epidemiological aspects of RAB32-PD, were published in Movement Disorders.

Author(s): 拉德費爾特,曼迪
Read publication

一項大型基因篩檢研究的初步觀察結果

出版品:遺傳性轉甲狀腺素蛋白相關澱粉樣變性持續觀察研究-首批3167名參與者的基線報告

要全面了解一種罕見疾病,需要識別大量的患者。自 2018 年以來,CENTOGENE 一直在進行一項針對遺傳性轉甲狀腺素蛋白相關澱粉樣變性 (hATTR) 的相關篩檢研究。對首批約 3000 名研究參與者的分析揭示了 hATTR 的許多新見解;該分析結果已發表在《臨床醫學雜誌》上。.

Author(s): 羅斯納,薩賓
Read publication

稀有免疫疾病揭秘

CBLB純合突變引起的免疫失調

免疫系統的穩態對人類健康至關重要。近期,CENTOGENE 對來自 CENTOGENE 生物資料庫的臨床和遺傳數據進行了分析,從而識別出患有一種極其罕見的免疫失調疾病的患者,該疾病的特徵是自身免疫和反覆發生的全身感染。.

Author(s): 詹森,艾琳
Read publication

An Encyclopedia for Mass Spectrometry Lipidomics

質譜(Mass Spectrometry, MS) 是目前用於脂質鑑定與定量分析的先進技術。本研究探討其在脂質體學中的應用,為疾病研究及提升全球患者健康照護奠定重要基礎。

質譜(Mass Spectrometry, MS) 是目前用於脂質鑑定與定量分析的先進技術。本研究探討其在脂質體學中的應用,為疾病研究及提升全球患者健康照護奠定重要基礎。

Read publication

A Multiomic Approach to Diagnosing Patients and Accelerating Treatments

透過整合基因檢測與生化檢測作為第一線診斷工具,協助遺傳性代謝疾病患者獲得更快速且更精準的診斷。

透過整合基因檢測與生化檢測作為第一線診斷工具,協助遺傳性代謝疾病患者獲得更快速且更精準的診斷。

Author(s): Bertoli-Avella, Aida M., MD
Read publication (PDF)

Retrospective Diagnosing of Rare Disease Patients

ASC-1 複合體功能異常於先天性神經肌肉疾病的進一步臨床與遺傳證據

儘管進行了診斷性外顯子組/基因組定序,但如果在分析時相關基因與疾病的關聯尚未明確,患者仍無法確診。因此,CENTOGENE 會定期對陰性病例進行重新評估,這通常有助於確診多名患者。近期在《歐洲醫學遺傳學雜誌》上發表了一系列關於一種新發現的神經肌肉疾病的病例報告。.

Author(s): Marais, Anett
Read publication

Broader Applicability of Rare Disease Biomarker

利用串聯質譜法定量分析戈謝氏症1型患者尿液中的生物標記譜

生物標記若能在大型患者和對照組組中得到充分錶徵,則具有應用於多種用途(診斷、預後、監測等)的潛力。 CENTOGENE依賴其豐富的罕見疾病樣本資源,積極支持已知和新型生物標記的相關研究。近期,《診斷學》(Diagnostics)雜誌發表了一項針對戈謝氏症的相關研究。.

Author(s): Curado, Filipa
Read publication

重症疾病的創新療法

高劑量氨溴索治療對神經性戈謝氏症患者的神經認知與運動發展有顯著療效 2

對於那些可能導致幼兒期死亡的疾病,探索性創新療法往往是值得追求且合理的。 CENTOGENE 很榮幸參與了一個相關的成功案例:一名患有戈謝病2型的新生兒在出生後的前三年接受了止咳藥的非適應症治療後,發育基本正常。該病例已發表在《神經病學前沿》(Frontiers in Neurology)雜誌上。.

Author(s): 哈特曼,圭多
Read publication

In-Depth Characterization of a Novel Disease

BUD13 的替代性剪接(Alternative Splicing)決定伴隨脂肪營養不良與早衰特徵之發育疾病的嚴重程度

建立新的基因-疾病關聯具有直接的診斷意義,而治療方案的發展則需要超越基因型和表現型的功能性見解。 CENTOGENE 的研究人員參與了一項近期研究,旨在應對這一挑戰。透過結合多種概念方法,研究人員不僅識別並解釋了一種新的疾病,還從 mRNA、蛋白質和亞細胞形態等層面對其進行了表徵。這項研究成果發表於《醫學遺傳學》(Genetics in Medicine)雜誌。.

Author(s): Bertoli-Avella, Aida M., MD
Read publication

Contributions to WGS Guidelines for Rare Disease Diagnostics

罕見疾病診斷之全基因體定序(WGS)建議指引

正確的基因診斷依賴於最新的指南。近期,一個歐洲專家小組對全基因組定序 (WGS) 的指南進行了修訂。 CENTOGENE 的首席基因組和醫學官 Peter Bauer 教授受邀擔任該專家組成員,凸顯了 CENTOGENE 在基因診斷領域的卓越聲譽。修訂後的指南已發表在《歐洲人類遺傳學雜誌》。.

Author(s): Bauer, Prof. Peter, MD
Read publication

透過描述大型患者群體來加深對疾病的理解

對單中心接受檢測的 97 例 CLN6 患者進行臨床和基因特徵分析

由於可用的患者群體規模較小,對特定罕見疾病的深入了解通常受到限制。 CENTOGENE 利用其生物資料庫克服了這一障礙,成功研究了巴頓病——一種兒童期起病的神經代謝疾病。對 97 名患者進行了全面且統一的特徵分析,這是迄今為止同類研究中規模最大的隊列,極大地拓展了我們對巴頓病的認識,並彰顯了 CENTOGENE 在罕見遺傳疾病領域的獨特地位。這項研究成果已發表於《罕見疾病孤兒網雜誌》(Orphanet Journal of Rare Diseases)。.

Author(s): 魯斯,科琳娜-馬塞拉
Read publication